STACEY GODMAN: Open Payments
NPI 1689902595 · WOBURN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 8 payments from 7 companies in 2025. Trend: 2023 $280 · 2024 $660 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $151 |
| TG Therapeutics, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $113 |
| Phathom Pharmaceuticals, Inc. | 1 | $101 |
| Novo Nordisk Inc | 1 | $100 |
| Alexion Pharmaceuticals, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: Gamunex-C, BRIUMVI, VOQUEZNA, ULTOMIRIS, NUCALA.
Industry payments across MA — which companies pay providers there.
